Reinnervate
Biotechnology company developing enabling technologies that facilitate research into cell growth and function in vitro.
Launch date
Market cap
-
Enterprise valuation
$528—792k (Dealroom.co estimates May 2014.)
Company register number 04468747
Sedgefield England (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
£1.6m | Series A | ||
£2.1m | Series B | ||
£1.1m | Early VC | ||
£100k | Seed | ||
Total Funding | $6.5m |
Related Content
Recent News about Reinnervate
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.